A company listed on Nasdaq has begun a review of strategic alternatives.
4 reports, 4 independent
Updated Jun 23
Gone quiet
Reached 4 outlets in its first 24 hours
- Reports
- 4
- Developments
- 6
- Repetition
- 25%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A company listed on Nasdaq has begun a review of strategic alternatives.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Bending Spoons acquired AOL, and the company (parent of Vimeo) plans to publicly trade on Nasdaq.Sub-event
- Rayonier Advanced Materials is exploring strategic alternatives to maximize shareholder value, utilizing Morgan Stanley for the strategic review.Sub-event
Company on Nasdaq facing fraud investigation and stock decline.1 source
- Hive company stock was traded on the Nasdaq exchange on June 6, 2026.Sub-event
Board appoints experienced leaders to guide strategic direction for the company.1 source
Company listed on Nasdaq initiates review of strategic alternatives.1 source
Keep exploring
The entities involved
-
company
legal entity representing an association of people, whether natural, legal or a mixture of both, with a specific objective
-
Nasdaq
American fully electronic stock exchange
-
board of directors
group of people who jointly supervise the activities of an organization
Related events
- Veri MedTech is seeking a debut on the Nasdaq exchange and is currently undergoing review by the SEC.
- MarketBeat is providing analyst ratings and price targets for Driven Brands, a consumer discretionary company traded on the Nasdaq stock exchange, alongside Arko.
- Rocket is utilizing Nasdaq for investor evaluation and the FDA reviewed Phase 2 efficacy data for its product RP-A501.
- Alvotech utilized Nasdaq for its public stock listing and is currently undergoing comprehensive review by the FDA for biosimilar applications.
- A new entity, Addvalue Solutions, incorporated in Singapore, is currently seeking a public listing on the Nasdaq stock exchange.